Cetera Advisor Networks’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,679
Closed -$489K 2926
2023
Q4
$489K Sell
22,679
-1,987
-8% -$36.7K ﹤0.01% 1898
2023
Q3
$459K Buy
24,666
+4,332
+21% +$101K ﹤0.01% 1829
2023
Q2
$515K Buy
20,334
+357
+2% +$8.98K ﹤0.01% 1691
2023
Q1
$517K Buy
19,977
+7,484
+60% +$200K ﹤0.01% 1668
2022
Q4
$295K Sell
12,493
-8,413
-40% -$227K ﹤0.01% 2000
2022
Q3
$530K Sell
20,906
-4,983
-19% -$175K 0.01% 1249
2022
Q2
$859K Buy
25,889
+13,099
+102% +$556K 0.01% 955
2022
Q1
$923K Buy
12,790
+2,151
+20% +$155K 0.01% 958
2021
Q4
$977K Buy
10,639
+1,004
+10% +$120K 0.01% 913
2021
Q3
$1.22M Buy
9,635
+1,930
+25% +$281K 0.02% 755
2021
Q2
$1.28M Buy
7,705
+1,511
+24% +$245K 0.02% 709
2021
Q1
$1.13M Sell
6,194
-1,094
-15% -$254K 0.02% 548
2020
Q4
$1.46M Sell
7,288
-3,128
-30% -$636K 0.03% 406
2020
Q3
$2.28M Buy
10,416
+1,735
+20% +$367K 0.06% 282
2020
Q2
$1.66M Buy
8,681
+5,919
+214% +$1.04M 0.04% 344
2020
Q1
$428K Buy
+2,762
New +$321K 0.01% 665

Other funds holding TDOC

Cetera Advisor Networks's TDOC Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 22,679 shares — an estimated $489K sold.

Cetera Advisor Networks first reported a position in TDOC in Q1 2020 and held it in 16 quarters. The position peaked at $2.28M in Q3 2020. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 22,679 Teladoc Health shares in Q1 2024, an estimated $489K.
  • Cetera Advisor Networks first reported a position in Teladoc Health in Q1 2020 and held it in 16 quarters.
  • Cetera Advisor Networks's Teladoc Health position peaked at $2.28M in Q3 2020.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.